About Centaur Pharmaceuticals Private Limited
Data last updated: 07 March 2026
Centaur Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 15 October 1980, the company has been in operation for over 46 years.
Registered with ROC Mumbai under CIN U24230MH1980PTC023291.
Capital: an authorised share capital of ₹20 Cr and a paid-up capital of ₹18.5 Cr. Formerly known as Centaur Pharmaceuticals Limited. It is led by directors including Rakhi Shridhar Kadam and Shivanand Dattatraya Sawant.
Last AGM: 13 August 2025. Financial statements filed for year ended 31 March 2025. Office: Centaur House Shanti Nagar Vakola Santacruz (E), Mumbai, Maharashtra, India – 400055.
As per the financials filed for FY 2025, the company reported a revenue of ₹1,060.17 Cr, a growth of 22% compared to the previous year.
The company has a workforce of approximately 3,274 employees as per the latest available data.
The company is associated with 1 brand - Centaur Pharmaceuticals. As per MCA filings, the company has open charges of ₹308 Cr and satisfied charges of ₹239.9 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website centaurpharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered AddressCentaur House Shanti Nagar Vakola Santacruz (E), Mumbai, Maharashtra, India – 400055
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited operates one associated brand: Centaur Pharmaceuticals. These brands represent Centaur Pharmaceuticals Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Branded formulations and APIs are developed and manufactured. | centaurpharma.com |
Competitors & Alternatives of Centaur Pharmaceuticals Private Limited
Brands and companies operating in the same space as Centaur Pharmaceuticals Private Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited is engaged in principal business activities including manufacturing and professional, scientific and technical, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products, scientific research and development. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
| M | Professional, Scientific and Technical | M5 | Scientific research and development | Locked |
Business activity turnover details for Centaur Pharmaceuticals Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited is audited by Deloitte Haskins & Sells LLP Name of auditor signing report BHATT for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Deloitte Haskins & Sells LLP Name of auditor signing report BHATT | Locked | Locked | Locked |
Complete auditor history for Centaur Pharmaceuticals Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited is currently managed by 7 directors, with 10 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rakhi Shridhar Kadam | Whole-Time Director | 14 Sep 2015 | 10 Years 10 Months | Current |
|
Shivanand Dattatraya Sawant
Also directs:
Minesfield Advisory Services Llp
|
Managing Director | 15 Oct 1980 | 45 Years 9 Months | Current |
| Sharadchandra Damodar Abhyankar | Director | 11 Aug 2016 | 9 Years 11 Months | Current |
| Supriya Samar Desai | Whole-Time Director | 21 Dec 2021 | 4 Years 7 Months | Current |
| Albert Taura | Director | 11 Aug 2016 | 9 Years 11 Months | Current |
| Smita Abhayakumar Phal | Whole-Time Director | 22 Jun 2011 | 15 Years 1 Months | Current |
Financials of Centaur Pharmaceuticals Private Limited FY 2025 filings available
Centaur Pharmaceuticals Private Limited reported revenue of ₹1,060.17 Cr (up 22.00% YoY) for FY 2025.
Ten-year financial statements for Centaur Pharmaceuticals Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Centaur Pharmaceuticals Private Limited
Shareholding and ownership data for Centaur Pharmaceuticals Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Centaur Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2011 | State Bank of India | ₹154 Cr | Open |
| 03 Aug 2006 | State Bank of India | ₹154 Cr | Open |
| 26 May 2015 | Tata Capital Financial Services Limited | ₹1.7 Cr | Satisfied |
| 27 Jan 2015 | Tata Capital Financial Services Limited | ₹3 Cr | Satisfied |
| 19 May 2014 | Tata Capital Financial Services Limited | ₹12.5 Cr | Satisfied |
Total charge records: 35 View all charges
Employees and EPFO Compliance at Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited has a workforce of 3,274 employees as of Oct 11, 2024.
Employee and EPFO history for Centaur Pharmaceuticals Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Centaur Pharmaceuticals Private Limited
GST registrations and filing compliance for Centaur Pharmaceuticals Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Centaur Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts for Centaur Pharmaceuticals Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Centaur Pharmaceuticals Private Limited
MSME payment history for Centaur Pharmaceuticals Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Centaur Pharmaceuticals Private Limited
Corporate group structure for Centaur Pharmaceuticals Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Centaur Pharmaceuticals Private Limited
MCA filings and documents for Centaur Pharmaceuticals Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Centaur Pharmaceuticals Private Limited
Recent News on Centaur Pharmaceuticals Private Limited
Frequently Asked Questions about Centaur Pharmaceuticals Private Limited
Centaur Pharmaceuticals Private Limited is an active private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 15 October 1980 (46+ years old) and is registered under CIN U24230MH1980PTC023291. The company has 3,274 employees.
Centaur Pharmaceuticals Private Limited reported revenue of ₹1,060.17 Cr for FY 2025 (up 22.00% YoY).
The current directors of Centaur Pharmaceuticals Private Limited are:
- Rakhi Shridhar Kadam - Whole-Time Director
- Shivanand Dattatraya Sawant - Managing Director
- Sharadchandra Damodar Abhyankar - Director
- Supriya Samar Desai - Whole-Time Director
- Albert Taura - Director
- Smita Abhayakumar Phal - Whole-Time Director
- Shreekant Dattathray Sawant - Managing Director
The primary industry of Centaur Pharmaceuticals Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Centaur Pharmaceuticals Private Limited can be reached at the registered office: Centaur House Shanti Nagar Vakola Santacruz E, Mumbai, Maharashtra, India – 400055, or through the website centaurpharma.com.
The authorised capital is ₹20 Cr, and the paid-up capital is ₹18.5 Cr.